Feedback / Questions
AL002 - Alector, AbbVie
latozinemab (GSK4527223) - Alector, GSK
https://www.globenewswire.com/news-release/2025/05/08/3077697/0/en/Alector-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next